Review



proteome profiler mouse phospho rtk array kit r d systems cat  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems proteome profiler mouse phospho rtk array kit r d systems cat
    Proteome Profiler Mouse Phospho Rtk Array Kit R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteome+profiler+mouse+phospho+rtk+array+kit/Proteome+Profiler+Mouse+Phospho-RTK+Array+Kit/pm41762656-249-72-78
    Average 94 stars, based on 78 article reviews
    proteome profiler mouse phospho rtk array kit r d systems cat - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Activation Assay:

    Article Title: The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI
    Article Snippet: .. Proteome Profiler Mouse Phospho-RTK Array Kit (R&D Systems, Minneapolis) was used to determine the Phospho RTK activation pattern. ..

    Article Title: The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.
    Article Snippet: .. Proteome Profiler Mouse Phospho-RTK Array Kit (R&D Systems, Minneapolis) was used to determine the Phospho RTK activation pattern. ..

    Article Title: The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI
    Article Snippet: .. Proteome Profiler Mouse Phospho-RTK Array Kit (R&D Systems, Minneapolis) was used to determine the Phospho RTK activation pattern. ..

    other:

    Article Title: Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers
    Article Snippet: Cells were seeded in 96-well flat-bottom plates, and growth rates were monitored using the IncuCyte Live Cell Analysis System (Roche Applied Sciences).

    Phospho-proteomics:

    Article Title: Tumorigenesis Driven by BRAF V600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
    Article Snippet: GTP-bound RAC1 was detected using the PAK1-p21–binding domain pull-down and detection kit (Thermo Scientific, #16118) as instructed by the manufacturer. .. Receptor tyrosine kinase (RTK) phosphorylation was measured using the Proteome Profiler Mouse Phospho-RTK Array Kit (R&D Systems, #ARY014) as instructed by the manufacturer. .. Gelatin degradation was measured using the QCM Gelatin Invadopodia Assay (Green; EMD Millipore, #ECM 670) following the manufacturer’s instructions.



    Similar Products

    proteome profiler mouse phospho rtk array kit r d systems cat  (R&D Systems)
    94
    R&D Systems proteome profiler mouse phospho rtk array kit r d systems cat
    Proteome Profiler Mouse Phospho Rtk Array Kit R D Systems Cat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteome+profiler+mouse+phospho+rtk+array+kit/Proteome+Profiler+Mouse+Phospho-RTK+Array+Kit/pm41762656-249-72-78
    Average 94 stars, based on 1 article reviews
    proteome profiler mouse phospho rtk array kit r d systems cat - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    proteome profiler mouse phospho rtk array kit  (R&D Systems)
    94
    R&D Systems proteome profiler mouse phospho rtk array kit
    NaJa cells differ in their response to drug treatment. A, Colony formation assay of NaJa cells treated with vemurafenib (V), encorafenib (E), and trametinib (T) at the indicated concentrations for 10 days. Shown is a representative result from three biological replicates. B–D, Quantification of the data shown in A . Data are presented as the mean ± SD and were normalized to the DMSO control ( n = 3). Statistical significance was calculated using one-way ANOVA and Dunnett multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. <t>E,</t> <t>Phospho-RTK</t> array of NaJa cells treated with 1 μmol/L vemurafenib (Vem), 0.5 μmol/L encorafenib (Enco), or 50 nmol/L trametinib (Tram) for 5 days. Shown are the log 2 FCs of treated cells versus DMSO control. Array membranes and cell line specific heatmaps are displayed in Supplementary Fig. S7. F, Western blot showing the effect of a 5-day treatment of the NaJa cells on various signaling pathways. G, Western blot and quantification of HER2 and HER3 ( n = 4). Basal EGFR expression was quantified based on data in ( F ), and five additional biological replicates normalized to the internal loading control. Data are presented as the mean ± SD and were normalized to NaJa-F for comparison. Statistical significance was calculated using one-way ANOVA and Tukey multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. H, Bulk RNA-seq of NaJa cells treated with 0.5 μmol/L encorafenib for 1 day or 5 days showing upregulation (red) or downregulation (blue) of ERK target genes and the adjusted P value (bubble size).
    Proteome Profiler Mouse Phospho Rtk Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteome+profiler+mouse+phospho+rtk+array+kit/Proteome+Profiler+Mouse+Phospho-RTK+Array+Kit/pmc13037773-150-14-21
    Average 94 stars, based on 1 article reviews
    proteome profiler mouse phospho rtk array kit - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    mouse phospho rtk array kit  (R&D Systems)
    94
    R&D Systems mouse phospho rtk array kit
    NaJa cells differ in their response to drug treatment. A, Colony formation assay of NaJa cells treated with vemurafenib (V), encorafenib (E), and trametinib (T) at the indicated concentrations for 10 days. Shown is a representative result from three biological replicates. B–D, Quantification of the data shown in A . Data are presented as the mean ± SD and were normalized to the DMSO control ( n = 3). Statistical significance was calculated using one-way ANOVA and Dunnett multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. <t>E,</t> <t>Phospho-RTK</t> array of NaJa cells treated with 1 μmol/L vemurafenib (Vem), 0.5 μmol/L encorafenib (Enco), or 50 nmol/L trametinib (Tram) for 5 days. Shown are the log 2 FCs of treated cells versus DMSO control. Array membranes and cell line specific heatmaps are displayed in Supplementary Fig. S7. F, Western blot showing the effect of a 5-day treatment of the NaJa cells on various signaling pathways. G, Western blot and quantification of HER2 and HER3 ( n = 4). Basal EGFR expression was quantified based on data in ( F ), and five additional biological replicates normalized to the internal loading control. Data are presented as the mean ± SD and were normalized to NaJa-F for comparison. Statistical significance was calculated using one-way ANOVA and Tukey multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. H, Bulk RNA-seq of NaJa cells treated with 0.5 μmol/L encorafenib for 1 day or 5 days showing upregulation (red) or downregulation (blue) of ERK target genes and the adjusted P value (bubble size).
    Mouse Phospho Rtk Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteome+profiler+mouse+phospho+rtk+array+kit/Proteome+Profiler+Mouse+Phospho-RTK+Array+Kit/pmc12580992-66-25-29
    Average 94 stars, based on 1 article reviews
    mouse phospho rtk array kit - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    ary001b mouse phospho rtk array kit r d systems  (R&D Systems)
    96
    R&D Systems ary001b mouse phospho rtk array kit r d systems
    NaJa cells differ in their response to drug treatment. A, Colony formation assay of NaJa cells treated with vemurafenib (V), encorafenib (E), and trametinib (T) at the indicated concentrations for 10 days. Shown is a representative result from three biological replicates. B–D, Quantification of the data shown in A . Data are presented as the mean ± SD and were normalized to the DMSO control ( n = 3). Statistical significance was calculated using one-way ANOVA and Dunnett multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. <t>E,</t> <t>Phospho-RTK</t> array of NaJa cells treated with 1 μmol/L vemurafenib (Vem), 0.5 μmol/L encorafenib (Enco), or 50 nmol/L trametinib (Tram) for 5 days. Shown are the log 2 FCs of treated cells versus DMSO control. Array membranes and cell line specific heatmaps are displayed in Supplementary Fig. S7. F, Western blot showing the effect of a 5-day treatment of the NaJa cells on various signaling pathways. G, Western blot and quantification of HER2 and HER3 ( n = 4). Basal EGFR expression was quantified based on data in ( F ), and five additional biological replicates normalized to the internal loading control. Data are presented as the mean ± SD and were normalized to NaJa-F for comparison. Statistical significance was calculated using one-way ANOVA and Tukey multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. H, Bulk RNA-seq of NaJa cells treated with 0.5 μmol/L encorafenib for 1 day or 5 days showing upregulation (red) or downregulation (blue) of ERK target genes and the adjusted P value (bubble size).
    Ary001b Mouse Phospho Rtk Array Kit R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteome+profiler+mouse+phospho+rtk+array+kit/Proteome+Profiler+Human+Phospho-RTK+Array+Kit/pm40086436-246-149-154
    Average 96 stars, based on 1 article reviews
    ary001b mouse phospho rtk array kit r d systems - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    NaJa cells differ in their response to drug treatment. A, Colony formation assay of NaJa cells treated with vemurafenib (V), encorafenib (E), and trametinib (T) at the indicated concentrations for 10 days. Shown is a representative result from three biological replicates. B–D, Quantification of the data shown in A . Data are presented as the mean ± SD and were normalized to the DMSO control ( n = 3). Statistical significance was calculated using one-way ANOVA and Dunnett multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. E, Phospho-RTK array of NaJa cells treated with 1 μmol/L vemurafenib (Vem), 0.5 μmol/L encorafenib (Enco), or 50 nmol/L trametinib (Tram) for 5 days. Shown are the log 2 FCs of treated cells versus DMSO control. Array membranes and cell line specific heatmaps are displayed in Supplementary Fig. S7. F, Western blot showing the effect of a 5-day treatment of the NaJa cells on various signaling pathways. G, Western blot and quantification of HER2 and HER3 ( n = 4). Basal EGFR expression was quantified based on data in ( F ), and five additional biological replicates normalized to the internal loading control. Data are presented as the mean ± SD and were normalized to NaJa-F for comparison. Statistical significance was calculated using one-way ANOVA and Tukey multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. H, Bulk RNA-seq of NaJa cells treated with 0.5 μmol/L encorafenib for 1 day or 5 days showing upregulation (red) or downregulation (blue) of ERK target genes and the adjusted P value (bubble size).

    Journal: Cancer Research Communications

    Article Title: Novel Syngeneic Cell Lines for Studying High-Risk BRAF V600E -Driven Colorectal Cancer In Vivo

    doi: 10.1158/2767-9764.CRC-25-0599

    Figure Lengend Snippet: NaJa cells differ in their response to drug treatment. A, Colony formation assay of NaJa cells treated with vemurafenib (V), encorafenib (E), and trametinib (T) at the indicated concentrations for 10 days. Shown is a representative result from three biological replicates. B–D, Quantification of the data shown in A . Data are presented as the mean ± SD and were normalized to the DMSO control ( n = 3). Statistical significance was calculated using one-way ANOVA and Dunnett multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. E, Phospho-RTK array of NaJa cells treated with 1 μmol/L vemurafenib (Vem), 0.5 μmol/L encorafenib (Enco), or 50 nmol/L trametinib (Tram) for 5 days. Shown are the log 2 FCs of treated cells versus DMSO control. Array membranes and cell line specific heatmaps are displayed in Supplementary Fig. S7. F, Western blot showing the effect of a 5-day treatment of the NaJa cells on various signaling pathways. G, Western blot and quantification of HER2 and HER3 ( n = 4). Basal EGFR expression was quantified based on data in ( F ), and five additional biological replicates normalized to the internal loading control. Data are presented as the mean ± SD and were normalized to NaJa-F for comparison. Statistical significance was calculated using one-way ANOVA and Tukey multiple comparisons test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001. H, Bulk RNA-seq of NaJa cells treated with 0.5 μmol/L encorafenib for 1 day or 5 days showing upregulation (red) or downregulation (blue) of ERK target genes and the adjusted P value (bubble size).

    Article Snippet: From each sample, the recommended amounts (250 μg) of protein were used for the Proteome Profiler Mouse Phospho-RTK Array Kit (ARY0141, R&D systems).

    Techniques: Colony Assay, Control, Western Blot, Protein-Protein interactions, Expressing, Comparison, RNA Sequencing